文献速递小儿骨科骨质疏松与代谢性骨病

奈立膦酸治疗儿童髋关节一过性骨质疏松症

Neridronate for transient osteoporosis of the hip in a child.
PubMed 文献 · Osteoporos Int · 2022-02-01

本文报告一例10岁儿童髋关节一过性骨质疏松症(TOH),并发股骨骨骺板骨折,经超说明书使用双膦酸盐(奈立膦酸)治疗后完全康复;作者建议对选择性青少年TOH病例可考虑介入性药物治疗,以预防股骨骨骺板不可逆损伤,并称这是首例儿童TOH使用奈立膦酸的报告。

要点

  • 儿童TOH罕见,可并发股骨骨骺板骨折,影响生长骨。
  • 本例10岁患儿经超说明书奈立膦酸治疗后完全康复。
  • 作者建议选择性青少年TOH病例可考虑介入性药物治疗。

核心结论

  • 作者建议对选择性青少年TOH病例可考虑介入性药物治疗,以预防股骨骨骺板可能的不可逆损伤。

研究设计与样本

  • 病例报告:一例10岁儿童TOH,就诊于作者所在儿科风湿病科,并汇总既往文献报告的儿童TOH病例。

主要发现

  • 本例为10岁儿童TOH,出现股骨骨骺板骨折这一不常见并发症。
  • 经超说明书双膦酸盐(奈立膦酸)治疗后完全康复。
  • 据作者所知,这是首例儿童TOH使用奈立膦酸的报告。

临床怎么用

  • 作者建议选择性青少年TOH病例可考虑介入性药物治疗。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Transient osteoporosis of the hip (TOH) is usually reported in middle-aged men or during pregnancy as a benign self-limiting condition. Nevertheless, its impact on quality of life in terms of pain and disability is considerable. Also, it can lead to insufficiency fractures or, more rarely, evolve into osteonecrosis. This condition is anecdotally described in the pediatric age and very little is known about how it may affect the growing bone. We herein describe a case of TOH in a 10-year-old child treated at our pediatric rheumatology service and summarize the pediatric cases of TOH previously reported in literature. There are two points of interest in our case report, the first one being the unusual complication of TOH with a femoral physis fracture and the second the complete recovery after the off-label therapy with bisphosphonates. We suggest that interventional medical treatment could be considered in selected cases of juvenile TOH, to prevent any possible irreversible damage on the femoral physis. As far as we know, this is the first report of neridronate employment in children affected by TOH.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Gaggiano C, Bardelli M, Tarsia M, et al. Neridronate for transient osteoporosis of the hip in a child. Osteoporos Int. 2022. PMID: 35106625. doi:10.1007/s00198-022-06324-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。